Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Oddbjørn, Brubakk"'
Publikováno v:
Journal of Infection. 52:92-96
Summary Objectives Multidrug resistant tuberculosis (MDR-TB) is an increasing problem in many parts of the world and in Norway the increase has been substantial since 1998. New therapies for MDR-TB have not been introduced since the fluoroquinolones
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62bce70ab0683194a5fedf6e76f4a24
https://doi.org/10.1016/j.jinf.2005.04.007
https://doi.org/10.1016/j.jinf.2005.04.007
Publikováno v:
Travel Medicine and Infectious Disease. 6:45-47
Hookworm-related cutaneous larva migrans is a common dermatosis in travellers to the tropics and typically presents as one or a few migrating serpiginous lesions on the lower extremities or buttocks. We present two Norwegian holidaymakers who develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fabd2ca27d0d4db12ac42c23bd28e559
https://doi.org/10.1016/j.tmaid.2007.09.043
https://doi.org/10.1016/j.tmaid.2007.09.043
Autor:
Oddbjørn, Brubakk
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 132(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1640ea22c391262772e5993ff587d8cf
https://pubmed.ncbi.nlm.nih.gov/22314720
https://pubmed.ncbi.nlm.nih.gov/22314720
Publikováno v:
American Journal of Noninvasive Cardiology. 7:220-224
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a701082d76192004bbaddeb9415abbbf
https://doi.org/10.1159/000470283
https://doi.org/10.1159/000470283
Autor:
Ingunn Brandt, Per Magnus, Harald Nyland, Oddbjørn Brubakk, Borgny Hedvig Wold, Tove Eidem, Geir Stene-Larsen, Hanne Nøkleby, Håkon K. Gjessing
Publikováno v:
Vaccine. 27(1)
The etiology of chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) is unknown. In Norway, a vaccine against Neisseria meningitides group B was administered to teenagers in 1988--1989 in a protection trial. In order to estimate the relative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab57f2d6cdfe5dfdb13499629096bac
https://pubmed.ncbi.nlm.nih.gov/18984023
https://pubmed.ncbi.nlm.nih.gov/18984023
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 127(15)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ae2c366ede7004ddc405960cf3502e2
https://pubmed.ncbi.nlm.nih.gov/17700733
https://pubmed.ncbi.nlm.nih.gov/17700733
Autor:
Oddbjørn, Brubakk
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 124(23)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ed82137a513e8af03fa83c61651fcc79
https://pubmed.ncbi.nlm.nih.gov/15593448
https://pubmed.ncbi.nlm.nih.gov/15593448
Publikováno v:
Archives of internal medicine. 158(7)
We describe 2 patients with a diagnosis of Whipple disease in whom the usual antibiotic therapy failed. A polymerase chain reaction–based test was used to identify the recently described Whipple bacillus, Tropheryma whippelii. In one case, the diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cad851e4bb7312d4de3b4d445256575e
https://pubmed.ncbi.nlm.nih.gov/9554687
https://pubmed.ncbi.nlm.nih.gov/9554687
Autor:
Oddbjørn Brubakk
Publikováno v:
Tidsskrift for Den norske legeforening. 132:927-927
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a02bd85711664b69aaadbff8c82d7783
https://doi.org/10.4045/tidsskr.12.0202
https://doi.org/10.4045/tidsskr.12.0202
Autor:
Tore Kalager, BjØrg Marit Andersen, Tom Bergan, OddbjØrn Brubakk, Johan N. Bruun, BØrge Døskeland, Kjell B. Hellum, Gunnar Hopen, Elisabeth Von Der Lippe, Vimala Rahm, StÅLe Ritland, Axel Schreiner
Publikováno v:
Scandinavian journal of infectious diseases. 24(5)
Sequential intravenous and oral ciprofloxacin (CF) was compared with a combination of tobramycin and cefuroxime (T/C) in the treatment of serious systemic infections. Altogether 310 patients were randomized, 160 receiving CF and 150 T/C, the 2 groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b00f9a7716b4659e71c75d32aa24e4
https://pubmed.ncbi.nlm.nih.gov/1465583
https://pubmed.ncbi.nlm.nih.gov/1465583